OPTIMAL SAMPLING TIMES IN BIOEQUIVALENCE TESTS

DOI10.1081/BIP-100101011MaRDI QIDQ4512648zbMATH OpenWikidataFDO

Authors Fan Hui Kong, René Gonin

Publication date 29 January 2001

Published in Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

zbMATH Keywords

bioequivalencecompartment modelbioavailabilityoptimal sampling designconcentration-time curve

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Optimal Sampling Times in Population Pharmacokinetic Studies
• Optimal confidence sets for testing average bioequivalence.
• Determining average bioequivalence and corresponding sample sizes in general asymmetric settings
• Statistical considerations in bioequivalence of two area under the concentration-time curves obtained from serial sampling data

Cites work

• Optimal selection procedures for abbreviated area under the curve (aauc) of blood concentration versus time for drug blood concentration levels

Cited in

(6)

• Sample reuse Simulation in Optimal Design for Tmax in Pharmacokinetic Experiments
• Optimal and Robust Designs for Estimating the Concentration Curve and the AUC
• Experimental designs for the estimation of the concentration curve and the AUC
• Optimal selection procedures for abbreviated area under the curve (aauc) of blood concentration versus time for drug blood concentration levels
• Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling
• Optimal Sampling Times in Population Pharmacokinetic Studies

This page was built for publication: OPTIMAL SAMPLING TIMES IN BIOEQUIVALENCE TESTS

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4512648)